Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Sandoz Limited, Frimley Business Park, Frimley, Surrey GU16 7SR, United Kingdom
Cefadroxil 500 mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsules, hard. Description: White, opaque capsule containing white to slightly yellowish powder. |
One capsule contains 500 mg of cefadroxil (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefadroxil |
Cefadroxil is a cephalosporin for oral administration which inhibits bacterial wall synthesis of actively dividing cells by binding to one or more penicillin-binding proteins. |
| List of Excipients |
|---|
|
Content: Magnesium stearate Shell: Titanium dioxide (E-171) |
Single packs of 10, 12, 14, 16, 20, 30, 40 and 100 (100 × 1) capsules.
Hospital packs of 100 (10 × 10) and 1000 (100 × 10) capsules in polyvinylchloride/polyvinylidene (PVC/PVDC)-Alu-blister strips.
Not all pack sizes may be marketed.
Sandoz Limited, Frimley Business Park, Frimley, Surrey GU16 7SR, United Kingdom
PL 04416/0433
Date of first authorisation: 16 February 1995
Date of last renewal: 01 April 2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
